Phase
Condition
Tic Disorders
Autism
Treatment
iTBS
Clinical Study ID
Ages 10-21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants of any sex, race, or ethnicity meeting all criteria listed below will be included in the study:
Aged 10-21 years
Fluent in English
DSM-5 diagnosis of TS, confirmed by the clinical team
Able to participate in the informed consent process, provide voluntary informedconsent/assent and provide a spontaneous narrative description of the key elementsof the study.
Clinical stability: determined by a physician, no switch of psychotropic medicationsor increase in dosage in the last 14 days from TMS treatment start; no change inother therapeutic interventions in last 14 days from TMS treatment start.
Exclusion
Exclusion Criteria:
Any neurodevelopmental, psychiatric condition other than TS, ADHD, or OCD, or mildanxiety based on review of K-SADS. Note - if an exclusionary psychiatric diagnosisis suspected based on K-SADS, the research physician will follow up with the parentand referral will be made to psychology or psychiatry as appropriate.
Presence of metallic foreign bodies or implanted medical devices.
Not meeting inclusion criteria as described above
Non-fluency in English, as English is the language in the validated clinicalquestionnaires, and the participant must be able to understand real-timeinstructions from the study staff
Study Design
Connect with a study center
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229
United StatesSite Not Available
Cincinnati Children's Hospital Medical Center
Cincinnati 4508722, Ohio 5165418 45229
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.